Bactex has developed a number of products, primarily vaccines for animals. Bactex continues to operate as a development stage company, developing new vaccines for animal and human use in partnership with large pharmaceutical firms. The company is currently seeking a partner to fund additional development on a human vaccine that is ready to enter clinical trials . MARS Enterprises, Inc . is a new company that has emerged from the University of Pittsburgh Medical Center in the information technology market segment. The MARS system has the capability to index every word and number in the database and to provide real-time searching and retrieval operations for all clinical, research and financial users.
Implementation is via a client-server architecture on a distributed parallel computational platform.
PTI is interested in expanding its business to include testing of new chemotherapeutic agents in association with pharmaceutical companies. It has raised money from Ben Franklin Partnership, Pittsburgh Biomedical Development Corporation and private investors.